b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31922030</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">2398-9238</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>3</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Jan</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Endocrinology, diabetes &amp; metabolism</Title>\n                <ISOAbbreviation>Endocrinol Diabetes Metab</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e00103</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/edm2.103</ELocationID>\n            <Abstract>\n                <AbstractText Label="Background" NlmCategory="UNASSIGNED">The EMPA-REG OUTCOME trial showed that empagliflozin reduced the risk of cardiovascular death and hospitalization for heart failure (HHF) in diabetic patients with cardiovascular disease. EMPRISE is a study programme on the effectiveness, safety and healthcare utilization of empagliflozin in routine care, leveraging real-world data from two commercial and one federal US data sources from 2014 to 2019.</AbstractText>\n                <AbstractText Label="Objectives" NlmCategory="UNASSIGNED">To describe rationale and design of EMPRISE, assess ability to minimize confounding and evaluate the time to reach sufficient statistical power for a key study outcome, HHF, using baseline information from the first year of EMPRISE.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">In 3 claims data sets, we identified a 1:1 propensity score (PS)-matched cohort of diabetic patients \xe2\x89\xa518\xc2\xa0years initiating empagliflozin or a dipeptidyl peptidase-4 inhibitor (DPP4i), resulting in 6643 total pairs. The PS model included &gt;140 baseline covariates. We measured covariate balance via standardized differences (SD) and postmatching c-statistic. We computed the incidence rate (IR) of HHF, predicted exposure accrual over time and calculated expected power.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">After PS matching, patient characteristics were balanced with SD &lt;0.1 and c-statistic between 0.54 and 0.59. The population IR of HHF was 4.4 per 1000 person-years using a specific HHF definition and 14.8 using a broader HHF definition. In our projection, 80%-powered analyses would require a minimum of 169 HHF events, expected to accumulate by year 3 (specific definition) or year 2 (broader definition).</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Baseline information from EMPRISE provided evidence of solid confounding control and adequate exposure accrual with expected powered analyses for the primary outcomes.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 The Authors. Endocrinology, Diabetes &amp; Metabolism published by John Wiley &amp; Sons Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Patorno</LastName>\n                    <ForeName>Elisabetta</ForeName>\n                    <Initials>E</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8809-9898</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Najafzadeh</LastName>\n                    <ForeName>Mehdi</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pawar</LastName>\n                    <ForeName>Ajinkya</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Franklin</LastName>\n                    <ForeName>Jessica M</ForeName>\n                    <Initials>JM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>D\xc3\xa9ruaz-Luyet</LastName>\n                    <ForeName>Anouk</ForeName>\n                    <Initials>A</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7396-7392</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Boehringer Ingelheim GmbH Ingelheim Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Brodovicz</LastName>\n                    <ForeName>Kimberly G</ForeName>\n                    <Initials>KG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield CT USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Santiago Ortiz</LastName>\n                    <ForeName>Adrian J</ForeName>\n                    <Initials>AJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bessette</LastName>\n                    <ForeName>Lily G</ForeName>\n                    <Initials>LG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kulldorff</LastName>\n                    <ForeName>Martin</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schneeweiss</LastName>\n                    <ForeName>Sebastian</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women\'s Hospital and Harvard Medical School Boston MA USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>R01 GM108999</GrantID>\n                    <Acronym>GM</Acronym>\n                    <Agency>NIGMS NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>26</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Endocrinol Diabetes Metab</MedlineTA>\n            <NlmUniqueID>101732442</NlmUniqueID>\n            <ISSNLinking>2398-9238</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">comparative effectiveness</Keyword>\n            <Keyword MajorTopicYN="N">confounding (epidemiology)</Keyword>\n            <Keyword MajorTopicYN="N">empagliflozin</Keyword>\n            <Keyword MajorTopicYN="N">heart failure</Keyword>\n            <Keyword MajorTopicYN="N">real\xe2\x80\x90world data</Keyword>\n            <Keyword MajorTopicYN="N">study validity</Keyword>\n            <Keyword MajorTopicYN="N">type 2 diabetes</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>03</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31922030</ArticleId>\n            <ArticleId IdType="doi">10.1002/edm2.103</ArticleId>\n            <ArticleId IdType="pii">EDM2103</ArticleId>\n            <ArticleId IdType="pmc">PMC6947693</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Ann Intern Med. 1997 Oct 15;127(8 Pt 2):757-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9382394</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2017 Dec;102(6):924-933</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28836267</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2018 Dec;41(12):2669-2701</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30291106</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Stat Med. 2014 May 10;33(10):1685-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24323618</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2017 Jun 8;376(23):2300-2302</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28591538</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Nov 26;373(22):2117-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26378978</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):596-603</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20140892</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Obes Metab. 2018 Apr;20(4):974-984</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29206336</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2011 Dec;90(6):777-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22048230</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2019 Jan 1;321(1):69-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30418475</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Intern Med. 2016 Jun 7;164(11):705-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27110660</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Jul 16;373(3):232-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26052984</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):989-990</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29697776</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharm Stat. 2011 Mar-Apr;10(2):150-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20925139</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2016 Mar;99(3):325-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26690726</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetologia. 2014 Nov;57(11):2237-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25212258</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Stroke. 2002 Oct;33(10):2465-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12364739</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2013 Oct 3;369(14):1327-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23992602</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am Heart J. 2004 Jul;148(1):99-104</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15215798</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epidemiology. 2014 Jan;25(1):126-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24240651</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Stat Med. 2009 Nov 10;28(25):3083-107</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19757444</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2016 Mar;99(3):262-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26659268</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Circulation. 2018 Apr 3;137(14):1432-1434</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29610125</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2018 Jan;41(1):6-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29263192</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2017 Aug 22;318(8):703-704</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28715550</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Nov 10;375(19):1834-1844</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27633186</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2017 Aug 17;377(7):644-657</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28605608</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1271-1276</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30165612</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2013 Oct 3;369(14):1317-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23992601</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Epidemiol. 2011 Jul;64(7):749-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21208778</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2015 Jan;38(1):140-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25538310</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2018 Jan;41(1):14-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29263194</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2015 Aug;38(8):e128-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26207068</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:129-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22262599</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):858-68</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20681003</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cardiovasc Diabetol. 2018 Jun 8;17(1):83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29884191</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Epidemiol. 2003 Nov 1;158(9):915-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14585769</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Saf. 2015 Mar;38(3):295-310</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25761856</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Jul 28;375(4):311-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27295427</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:69-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22552982</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Heart Assoc. 2018 Mar 10;7(6):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29525786</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacol Ther. 2012 Jul;92(1):80-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22588606</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2012 Dec;35(12):2665-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23173135</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2018 Jan;41(Suppl 1):S73-S85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29222379</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'